| Risk | High |
|---|---|
| Min SIP Amount | ₹500 |
| Expense Ratio | 1.24% |
| NAV | ₹119.9 (21 May 2019) |
|---|---|
| Fund Started | 01 Jan 2013 |
| Fund Size | ₹1,032 Cr |
| Name | Sector | Instrument | % Assets |
|---|---|---|---|
| Cipla Ltd. | Healthcare | Equity | 9.8% |
| Sun Pharmaceutical Inds. Ltd. | Healthcare | Equity | 8.3% |
| Divi's Laboratories Ltd. | Healthcare | Equity | 8.3% |
| Strides Pharma Science Ltd. | Healthcare | Equity | 6.9% |
| Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 6.2% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 5.8% |
| Cadila Healthcare Ltd. | Healthcare | Equity | 5.4% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 5.1% |
| Gufic Biosciences Ltd. | Healthcare | Equity | 4.6% |
| Aster DM Healthcare Ltd. | Healthcare | Equity | 3.5% |
SBI Mutual Fund started their mutual fund on 29/06/1987 and its managing total assets of ₹1,88,455 Cr. Its ranked at 5 as per total assets at end of 30th Sep 2017.
With a robust and wealthy history of the State Bank of India cluster, SBI Funds Management Pvt. Ltd. has been serving to millions of investors through their years of experience. With a wide network of over 222 service points across India, SBI has been delivering to value and create trust amongst investors. They have systematically delivered the optimum worth to its investors over the years. SBI Funds Management company has joined the key players within the Indian investment trust business with an array of funds in multiple sectors like money establishments, native and international quality management corporations, pension funds, etc. SBI MF has conjointly unified end-to-end made-to-order quality management product for establishments, discretionary and non-discretionary portfolio management services.
SBI Funds Management has been effectively managing and guiding India’s dedicated offshore funds since 1988. SBI Funds Management is famed because it was the 1st bank to come up with ‘SBI Resurgent Asian nation Opportunities Fund’. The target for these funds was to supply investors with never-before opportunities in semi-permanent growth in capital in a very kind of stocks of Indian corporations.